The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Zhejiang University
Fudan University
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
The First Affiliated Hospital of Bengbu Medical University
Central European Society for Anticancer Drug Research
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
ChineseAMS
Merrimack Pharmaceuticals
AHS Cancer Control Alberta
Alaunos Therapeutics
National Cancer Institute (NCI)